← Back to Search

Behavioural Intervention

Older Adults Gamma (OAg) for Aging (Multimodal Trial)

N/A
Recruiting
Led By Psyche Loui, PhD
Research Sponsored by Northeastern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No recent history of neurological or psychiatric disorders, including mood disorders
No more than mild hearing loss
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Multimodal Trial Summary

This trial aims to study the effects of using music as a form of brain stimulation on working memory in older and younger adults. The participants will be randomly assigned to receive either the music stimulation or a sham

Who is the study for?
This trial is for older and younger adults with normal or corrected vision, mild or no hearing loss, no recent neurological/psychiatric disorders, and not on medication affecting cognition/music response. Those with moderate/severe hearing loss, uncorrectable visual impairment, unstable medication for cognition, major neurologic conditions or serious health issues are excluded.Check my eligibility
What is being tested?
The study investigates the impact of multimodal musical stimulation versus sham (control) on working memory in aging individuals. It's a Stage I randomized controlled trial that also examines brain activity through electroencephalography to see if music can reverse cognitive decline.See study design
What are the potential side effects?
Since this intervention involves musical stimulation rather than drugs or invasive procedures, significant side effects are not anticipated. However, participants may experience fatigue or discomfort from wearing EEG equipment during the study.

Multimodal Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have not had recent mental health or neurological issues.
Select...
I have mild or no hearing loss.
Select...
My vision is normal or corrected to normal.

Multimodal Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
EEG
Secondary outcome measures
Working Memory

Multimodal Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Older Adults Gamma (OAg)Experimental Treatment1 Intervention
The assignment of older adults to OA and OAg will be randomized. The within-subjects factor of stimulation modality includes 2 levels, to be administered in counterbalanced order: Visual (V, i.e., lights-only) and Audiovisual (AV, i.e., music-plus-lights). Each subject will be aware that they are receiving V and AV stimulation, and thus infer that we are comparing these two forms of stimulation and therefore assessing the effects of music. However, and important to the design of this study, all subjects will be blinded with respect to their group assignment; i.e., they will not know, until post-study debriefing, about the other arms of the study, and that the gamma-band stimulation is an active ingredient of the intervention.
Group II: Older Adults (OA)Placebo Group1 Intervention
The assignment of older adults to OA and OAg will be randomized. The within-subjects factor of stimulation modality includes 2 levels, to be administered in counterbalanced order: Visual (V, i.e., lights-only) and Audiovisual (AV, i.e., music-plus-lights). Each subject will be aware that they are receiving V and AV stimulation, and thus infer that we are comparing these two forms of stimulation and therefore assessing the effects of music. However, and important to the design of this study, all subjects will be blinded with respect to their group assignment; i.e., they will not know, until post-study debriefing, about the other arms of the study, and that the gamma-band stimulation is an active ingredient of the intervention.

Find a Location

Who is running the clinical trial?

Northeastern UniversityLead Sponsor
88 Previous Clinical Trials
61,210 Total Patients Enrolled
4 Trials studying Aging
377 Patients Enrolled for Aging
Psyche Loui, PhDPrincipal InvestigatorNortheastern University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to participate in this medical study?

"To be considered eligible for participation in this clinical trial, prospective candidates must meet the age requirement of being between 18 and 95 years old. The study aims to recruit approximately 100 patients."

Answered by AI

Are new participants still being accepted for enrollment in this ongoing research study?

"According to the latest information available on clinicaltrials.gov, this trial is actively seeking participants. The initial posting of the study took place on December 11th, 2022 and it was last updated on January 18th, 2024."

Answered by AI

What is the current number of individuals participating in this clinical investigation?

"Indeed, the details provided on clinicaltrials.gov indicate that this specific clinical trial is actively seeking participants. It was initially posted on December 11th, 2022 and its most recent update occurred on January 18th, 2024. The study aims to recruit a total of 100 patients from a single designated site."

Answered by AI

Are individuals aged 70 and above eligible for enrollment in this medical study?

"To be eligible for this clinical trial, individuals must fall within the age range of 18 to 95 years old. It is important to note that there are separate studies available for participants under the age of 18 (1 study) and those over the age of 65 (223 studies)."

Answered by AI
~33 spots leftby Dec 2024